Published in Lancet Infect Dis on January 01, 2014
Middle East Respiratory Syndrome. N Engl J Med (2017) 0.91
Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus. Emerg Infect Dis (2016) 0.85
Estimating the Severity and Subclinical Burden of Middle East Respiratory Syndrome Coronavirus Infection in the Kingdom of Saudi Arabia. Am J Epidemiol (2016) 0.78
Stratified infection medicine: a call to arms. Lancet Infect Dis (2014) 0.75
Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola. Ann Transl Med (2016) 0.75
Modernising epidemic science: enabling patient-centred research during epidemics. BMC Med (2016) 0.75
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med (2013) 24.88
A comprehensive catalogue of somatic mutations from a human cancer genome. Nature (2009) 24.27
A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature (2009) 18.39
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 17.37
Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74
A randomized trial of protocol-based care for early septic shock. N Engl J Med (2014) 16.05
Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med (2005) 15.53
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med (2006) 14.21
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature (2011) 13.30
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature (2011) 13.18
Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA (2009) 13.00
Avian influenza A (H5N1) infection in humans. N Engl J Med (2005) 12.95
A network-based analysis of systemic inflammation in humans. Nature (2005) 12.60
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet (2010) 12.43
Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med (2013) 11.85
International study of the prevalence and outcomes of infection in intensive care units. JAMA (2009) 11.57
Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med (2004) 11.31
Mutational processes molding the genomes of 21 breast cancers. Cell (2012) 11.22
Mortality after fluid bolus in African children with severe infection. N Engl J Med (2011) 10.99
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
The life history of 21 breast cancers. Cell (2012) 10.59
Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med (2008) 10.27
Dengue: a continuing global threat. Nat Rev Microbiol (2010) 9.96
Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med (2010) 9.90
Physician staffing patterns and clinical outcomes in critically ill patients: a systematic review. JAMA (2002) 9.89
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA (2009) 9.47
Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA (2009) 9.41
RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care (2006) 9.29
Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet (2004) 8.62
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2007) 8.33
Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis (2012) 8.02
A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med (2008) 7.73
Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study. J Clin Oncol (2007) 7.67
Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med (2013) 7.52
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med (2008) 7.49
Withdrawal of mechanical ventilation in anticipation of death in the intensive care unit. N Engl J Med (2003) 7.32
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med (2008) 7.28
Non-pharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis (2006) 6.85
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med (2010) 6.69
A genomic storm in critically injured humans. J Exp Med (2011) 6.67
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis (2009) 6.52
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet (2003) 6.52
Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med (2005) 6.47
A promoter-level mammalian expression atlas. Nature (2014) 6.25
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea. N Engl J Med (2016) 6.22
Influenza. Lancet (2003) 6.08
National estimates of severe sepsis in United States emergency departments. Crit Care Med (2007) 5.99
Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med (2007) 5.65
A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer. J Clin Oncol (2008) 5.56
The international Ebola emergency. N Engl J Med (2014) 5.35
A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis (2012) 5.24
Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med (2002) 5.24
Nighttime intensivist staffing and mortality among critically ill patients. N Engl J Med (2012) 5.22
Early intensive care sedation predicts long-term mortality in ventilated critically ill patients. Am J Respir Crit Care Med (2012) 5.15
C.A.U.S.E.: Cardiac arrest ultra-sound exam--a better approach to managing patients in primary non-arrhythmogenic cardiac arrest. Resuscitation (2007) 5.04
Variation in critical care services across North America and Western Europe. Crit Care Med (2008) 5.00
Evolutionary history of Salmonella typhi. Science (2006) 5.00
Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol (2013) 4.98
Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med (2014) 4.79
The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med (2002) 4.72
IFITM3 restricts the morbidity and mortality associated with influenza. Nature (2012) 4.66
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med (2010) 4.64
H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet (2007) 4.62
Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet (2013) 4.57
The effect of multidisciplinary care teams on intensive care unit mortality. Arch Intern Med (2010) 4.41
Non-pharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis (2006) 4.34
Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003. J Infect Dis (2005) 4.33
Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol (2004) 4.33
Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30
Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA (2011) 4.24
Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet (2008) 4.17
A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ (2008) 4.11
Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis. N Engl J Med (2016) 4.11
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother (2006) 4.02
LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev (2007) 3.96
The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog (2008) 3.79
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA (2013) 3.78
Kinetics of influenza A virus infection in humans. J Virol (2006) 3.78
Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet (2013) 3.77
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg Infect Dis (2009) 3.76
Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet (2004) 3.72
Human metapneumovirus as a cause of community-acquired respiratory illness. Emerg Infect Dis (2002) 3.66
Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med (2007) 3.63
Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis. N Engl J Med (2016) 3.59